Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.

Bildik, Gamze

Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells. [electronic resource] - Cell death & disease 04 2018 - 421 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2041-4889

10.1038/s41419-018-0459-3 doi


Acetonitriles--pharmacology
Animals
Anthracenes--pharmacology
Anti-Mullerian Hormone--blood
Apoptosis--drug effects
Benzothiazoles--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Estradiol--metabolism
Female
G2 Phase Cell Cycle Checkpoints--drug effects
Granulosa Cell Tumor--drug therapy
Humans
JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors
Mice
Mice, SCID
Mitosis
Ovarian Neoplasms--drug therapy
RNA Interference
RNA, Small Interfering--metabolism
Signal Transduction--drug effects